3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
Specimen Handling
258
Magnetic Resonance Spectroscopy
213
pembrolizumab
202
Carboplatin
170
Cisplatin
137
Biopsy
133
Cyclophosphamide
130
Paclitaxel
120
Nivolumab
109
Gemcitabine
102
Bevacizumab
102
Radiotherapy
81
Dexamethasone
77
Pemetrexed
75
atezolizumab
71
Fluorouracil
71
fludarabine
68
Doxorubicin
67
Leucovorin
66
Docetaxel
65
Radiation
64
Oxaliplatin
62
Rituximab
60
venetoclax
58
Prednisone
57
Cetuximab
54
durvalumab
53
Vincristine
52
Etoposide
51
130-nm albumin-bound paclitaxel
51
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carvedilol
×
30 days
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled